AIRS Medical, a global AI solutions provider for medical imaging, has secured a strategic growth investment from TA Associates to accelerate its international expansion and product development. The investment will support advancement of the company's AI-powered MRI technologies designed to improve imaging efficiency and expand patient access. Founded in 2018, AIRS Medical develops AI-native MRI acceleration and reconstruction software. The company currently supports over 1,700 healthcare institutions across more than 40 countries, with its technologies used in approximately 6 million MRI examinations annually. AIRS Medical's product suite includes SwiftMR, an AI-powered MRI acceleration and image enhancement solution, and SwiftSight, an MRI quantification and structured reporting platform. The company aims to address growing imaging demand and limited capacity challenges facing healthcare providers globally.

Recens Medical, a precision cooling technology company, has set its initial public offering price at KRW 11,000, the top of its indicative range of KRW 9,000-11,000. The bookbuilding attracted 2,261 institutional investors, achieving a subscription rate of 1,352.63 to 1, the highest among Korean IPOs this year. All participating institutions bid at or above the upper range, with 63.9% of orders including lock-up commitments of at least 15 days. The company will raise approximately KRW 15.4 billion through the offering, with an expected market capitalisation of around KRW 119.4 billion. Retail investor subscriptions are scheduled for 19-20 February, with a KOSDAQ listing planned for March. Proceeds will fund manufacturing automation, clinical trials for new indications, and global marketing expansion.